vs

Side-by-side financial comparison of COASTAL FINANCIAL CORP (CCB) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.

PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $138.0M, roughly 1.2× COASTAL FINANCIAL CORP). On growth, COASTAL FINANCIAL CORP posted the faster year-over-year revenue change (-5.8% vs -22.7%). COASTAL FINANCIAL CORP produced more free cash flow last quarter ($246.1M vs $-36.6M). Over the past eight quarters, COASTAL FINANCIAL CORP's revenue compounded faster (-3.6% CAGR vs -11.5%).

Fidelity National Financial, Inc., is an American provider of title insurance and settlement services to the real estate and mortgage industries. A Fortune 500 company, Fidelity National Financial generated approximately $8.469 billion in annual revenue in 2019 from its title and real estate-related operations. The company was the first instance of an attorney licensed by a Native American Tribe being certified as "authorized house counsel" in the state of Florida.

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

CCB vs PTCT — Head-to-Head

Bigger by revenue
PTCT
PTCT
1.2× larger
PTCT
$164.7M
$138.0M
CCB
Growing faster (revenue YoY)
CCB
CCB
+17.0% gap
CCB
-5.8%
-22.7%
PTCT
More free cash flow
CCB
CCB
$282.8M more FCF
CCB
$246.1M
$-36.6M
PTCT
Faster 2-yr revenue CAGR
CCB
CCB
Annualised
CCB
-3.6%
-11.5%
PTCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCB
CCB
PTCT
PTCT
Revenue
$138.0M
$164.7M
Net Profit
$-135.0M
Gross Margin
Operating Margin
12.4%
-43.3%
Net Margin
-82.0%
Revenue YoY
-5.8%
-22.7%
Net Profit YoY
-104.8%
EPS (diluted)
$0.84
$-1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCB
CCB
PTCT
PTCT
Q4 25
$138.0M
$164.7M
Q3 25
$144.7M
$211.0M
Q2 25
$119.4M
$178.9M
Q1 25
$139.5M
$1.2B
Q4 24
$146.5M
$213.2M
Q3 24
$151.1M
$196.8M
Q2 24
$135.3M
$186.7M
Q1 24
$148.4M
$210.1M
Net Profit
CCB
CCB
PTCT
PTCT
Q4 25
$-135.0M
Q3 25
$13.6M
$15.9M
Q2 25
$11.0M
$-64.8M
Q1 25
$9.7M
$866.6M
Q4 24
$-65.9M
Q3 24
$13.5M
$-106.7M
Q2 24
$11.6M
$-99.2M
Q1 24
$6.8M
$-91.6M
Operating Margin
CCB
CCB
PTCT
PTCT
Q4 25
12.4%
-43.3%
Q3 25
12.4%
1.4%
Q2 25
12.0%
-19.5%
Q1 25
8.4%
82.5%
Q4 24
11.7%
-76.2%
Q3 24
10.8%
-27.7%
Q2 24
11.1%
-21.5%
Q1 24
5.9%
-21.6%
Net Margin
CCB
CCB
PTCT
PTCT
Q4 25
-82.0%
Q3 25
9.4%
7.5%
Q2 25
9.2%
-36.3%
Q1 25
7.0%
73.7%
Q4 24
-30.9%
Q3 24
8.9%
-54.2%
Q2 24
8.6%
-53.1%
Q1 24
4.6%
-43.6%
EPS (diluted)
CCB
CCB
PTCT
PTCT
Q4 25
$0.84
$-1.63
Q3 25
$0.88
$0.20
Q2 25
$0.71
$-0.83
Q1 25
$0.63
$10.04
Q4 24
$0.95
$-0.85
Q3 24
$0.97
$-1.39
Q2 24
$0.84
$-1.29
Q1 24
$0.50
$-1.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCB
CCB
PTCT
PTCT
Cash + ST InvestmentsLiquidity on hand
$1.9B
Total DebtLower is stronger
Stockholders' EquityBook value
$491.0M
$-205.3M
Total Assets
$4.7B
$2.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCB
CCB
PTCT
PTCT
Q4 25
$1.9B
Q3 25
$1.7B
Q2 25
$2.0B
Q1 25
$2.0B
Q4 24
$1.1B
Q3 24
$1.0B
Q2 24
$1.1B
Q1 24
$884.8M
Stockholders' Equity
CCB
CCB
PTCT
PTCT
Q4 25
$491.0M
$-205.3M
Q3 25
$475.3M
$-155.8M
Q2 25
$461.7M
$-206.5M
Q1 25
$449.9M
$-185.8M
Q4 24
$438.7M
$-1.1B
Q3 24
$331.9M
$-1.1B
Q2 24
$316.7M
$-980.2M
Q1 24
$303.7M
$-893.9M
Total Assets
CCB
CCB
PTCT
PTCT
Q4 25
$4.7B
$2.9B
Q3 25
$4.6B
$2.6B
Q2 25
$4.5B
$2.6B
Q1 25
$4.3B
$2.7B
Q4 24
$4.1B
$1.7B
Q3 24
$4.1B
$1.8B
Q2 24
$4.0B
$1.9B
Q1 24
$3.9B
$1.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCB
CCB
PTCT
PTCT
Operating Cash FlowLast quarter
$254.6M
$-34.3M
Free Cash FlowOCF − Capex
$246.1M
$-36.6M
FCF MarginFCF / Revenue
178.3%
-22.3%
Capex IntensityCapex / Revenue
6.1%
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$436.4M
$702.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCB
CCB
PTCT
PTCT
Q4 25
$254.6M
$-34.3M
Q3 25
$59.0M
$-66.3M
Q2 25
$66.0M
$-58.3M
Q1 25
$71.7M
$870.1M
Q4 24
$259.8M
$-30.0M
Q3 24
$62.6M
$-77.0M
Q2 24
$72.1M
$-71.5M
Q1 24
$56.8M
$70.8M
Free Cash Flow
CCB
CCB
PTCT
PTCT
Q4 25
$246.1M
$-36.6M
Q3 25
$57.4M
$-69.7M
Q2 25
$64.0M
$-59.6M
Q1 25
$68.9M
$868.4M
Q4 24
$249.9M
$-33.8M
Q3 24
$60.2M
$-77.5M
Q2 24
$69.5M
$-78.8M
Q1 24
$55.0M
$61.2M
FCF Margin
CCB
CCB
PTCT
PTCT
Q4 25
178.3%
-22.3%
Q3 25
39.7%
-33.1%
Q2 25
53.6%
-33.3%
Q1 25
49.4%
73.8%
Q4 24
170.6%
-15.8%
Q3 24
39.8%
-39.4%
Q2 24
51.3%
-42.2%
Q1 24
37.1%
29.1%
Capex Intensity
CCB
CCB
PTCT
PTCT
Q4 25
6.1%
1.4%
Q3 25
1.2%
1.6%
Q2 25
1.7%
0.7%
Q1 25
2.0%
0.1%
Q4 24
6.8%
1.8%
Q3 24
1.6%
0.3%
Q2 24
1.9%
4.0%
Q1 24
1.2%
4.6%
Cash Conversion
CCB
CCB
PTCT
PTCT
Q4 25
Q3 25
4.34×
-4.17×
Q2 25
5.99×
Q1 25
7.37×
1.00×
Q4 24
Q3 24
4.65×
Q2 24
6.22×
Q1 24
8.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCB
CCB

Other$74.7M54%
Baa S Credit Enhancements$47.3M34%
Baa S Program Income$8.4M6%
Transaction Fees$4.9M4%
Servicing And Other Baa S Fees$1.6M1%
Baa S Fraud Enhancements$1.1M1%

PTCT
PTCT

Segment breakdown not available.

Related Comparisons